Stay updated on Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has updated its date references, adding new dates in March 2025 while removing older dates from January and February 2025.
    Difference
    0.7%
    Check dated 2025-03-12T05:16:11.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-25T19:08:32.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-11T07:35:34.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has updated the results reporting dates for a study on pembrolizumab, including new completion and posting dates, while removing previous estimates and details about the study's status and protocol revisions.
    Difference
    7%
    Check dated 2025-02-04T03:25:09.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T20:37:00.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.3%
    Check dated 2025-01-12T17:14:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.